Devaraja Rajasekaran
Impact in
-
- Cancer Mechanisms and Therapy
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer Mechanisms and Therapy 14
-
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Devanand Sarkar (16 shared papers)Paul B. Fisher (16 shared papers)Chadia L. Robertson (15 shared papers)Maaged Akiel (13 shared papers)Rachel Gredler (13 shared papers)Jyoti Srivastava (11 shared papers)Ayesha Siddiq (11 shared papers)Nidhi Jariwala (8 shared papers)
- Journals
- Cancer Research (5 papers)Journal of Biological Chemistry (3 papers)Biochemical Journal (2 papers)Bioconjugate Chemistry (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesIndiaJapan
In The Last Decade
Devaraja Rajasekaran
24 papers receiving 754 citations
Peers
Comparison fields: 5 of 88
- Pathology and Forensic Medicine 283
- Cancer Research 127
- Biochemistry 48
- Oncology 161
- Molecular Biology 337
Countries citing papers authored by Devaraja Rajasekaran
This map shows the geographic impact of Devaraja Rajasekaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devaraja Rajasekaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devaraja Rajasekaran more than expected).
Fields of papers citing papers by Devaraja Rajasekaran
This network shows the impact of papers produced by Devaraja Rajasekaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devaraja Rajasekaran. The network helps show where Devaraja Rajasekaran may publish in the future.
Co-authors
The 25 scholars most cited alongside Devaraja Rajasekaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 94 | |
| 2 | 2014 | 55 | |
| 3 | 2017 | 52 | |
| 4 | 2017 | 51 | |
| 5 | 2014 | 46 | |
| 6 | 2015 | 45 | |
| 7 | 2014 | 43 | |
| 8 | The transcription factor LSF: a novel oncogene for hepatocellular carcinoma. | 2012 | 43 |
| 9 | 2014 | 41 | |
| 10 | 2014 | 40 | |
| 11 | 2016 | 34 | |
| 12 | 2020 | 30 | |
| 13 | 2008 | 26 | |
| 14 | 2015 | 22 | |
| 15 | 2015 | 22 | |
| 16 | 2015 | 21 | |
| 17 | 2015 | 20 | |
| 18 | 2022 | 17 | |
| 19 | 2021 | 14 | |
| 20 | 2008 | 11 |
About Devaraja Rajasekaran
Devaraja Rajasekaran is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Immunology and Cancer Research, having authored 24 papers that have together received 757 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (14 papers), Peptidase Inhibition and Analysis (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Circular RNAs in diseases (3 papers), Macrophage Migration Inhibitory Factor (3 papers), Ubiquitin and proteasome pathways (2 papers), Nuclear Receptors and Signaling (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (283 citations), Cancer Research (127 citations), Biochemistry (48 citations), Oncology (161 citations) and Molecular Biology (337 citations). Devaraja Rajasekaran has collaborated with scholars based in United States, India and Japan. Frequent co-authors include Devanand Sarkar, Paul B. Fisher, Chadia L. Robertson, Maaged Akiel, Rachel Gredler, Jyoti Srivastava, Ayesha Siddiq, Nidhi Jariwala, Luni Emdad and Jolene J. Windle. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Biochemical Journal, Bioconjugate Chemistry and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.